{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:35Z","timestamp":1762875215963},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11908-008-0077-9","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T06:27:22Z","timestamp":1227335242000},"page":"473-479","source":"Crossref","is-referenced-by-count":6,"title":["Treatment options in emerging mold infections"],"prefix":"10.1007","volume":"10","author":[{"given":"Patricia","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,23]]},"reference":[{"key":"77_CR1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/383319","volume":"38","author":"M. Nucci","year":"2004","unstructured":"Nucci M, Marr KA, Queiroz-Telles F, et al.: Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004, 38:1237\u20131242.","journal-title":"Clin Infect Dis"},{"key":"77_CR2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1439-0507.2005.01132.x","volume":"48","author":"J. Singh","year":"2005","unstructured":"Singh J, Rimek D, Kappe R: In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 2005, 48:246\u2013250.","journal-title":"Mycoses"},{"key":"77_CR3","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","volume":"50","author":"F. Sabatelli","year":"2006","unstructured":"Sabatelli F, Patel R, Mann PA, et al.: In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006, 50:2009\u20132015.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1439-0507.2004.00959.x","volume":"47","author":"D.P. Eisen","year":"2004","unstructured":"Eisen DP, Robson J: Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis. Mycoses 2004, 47:159\u2013162.","journal-title":"Mycoses"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","volume":"51","author":"E. Dannaoui","year":"2003","unstructured":"Dannaoui E, Meletiadis J, Mouton JW, et al.: In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003, 51:45\u201352.","journal-title":"J Antimicrob Chemother"},{"key":"77_CR6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","volume":"51","author":"M. Torres-Narbona","year":"2007","unstructured":"Torres-Narbona M, Guinea J, Martinez-Alarc\u00f3n J, et al.: In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother 2007, 51:1126\u20131129.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR7","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","volume":"51","author":"M. Guembe","year":"2007","unstructured":"Guembe M, Guinea J, Pel\u00e1ez T, et al.: Synergistic effect of posaconazole and caspofungin against clinical zygomycetes. Antimicrob Agents Chemother 2007, 51:3457\u20133458.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","volume":"52","author":"J. Guinea","year":"2008","unstructured":"Guinea J, Pel\u00e1ez T, Recio S, et al.: In vitro antifungal activity of isavuconazole (BAL4815), voriconazole, and fluconazole against 1007 isolates of zygomycetes, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother 2008, 52:1396\u20131400.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","volume":"30","author":"D.P. Kontoyiannis","year":"2000","unstructured":"Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV: Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000, 30:851\u2013856.","journal-title":"Clin Infect Dis"},{"issue":"Suppl1","key":"77_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1470-9465.2004.00843.x","volume":"10","author":"R.M. Prabhu","year":"2004","unstructured":"Prabhu RM, Patel R: Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004, 10(Suppl 1):31\u201347.","journal-title":"Clin Microbiol Infect"},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/10428190310001653691","volume":"45","author":"B. Gleissner","year":"2004","unstructured":"Gleissner B, Schilling A, Anagnostopolous I, et al.: Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004, 45:1351\u20131360.","journal-title":"Leuk Lymphoma"},{"key":"77_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/clinids\/8.3.441","volume":"8","author":"G. Morduchowicz","year":"1986","unstructured":"Morduchowicz G, Shmueli D, Shapira Z, et al.: Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of the literature. Rev Infect Dis 1986, 8:441\u2013446.","journal-title":"Rev Infect Dis"},{"key":"77_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","volume":"40","author":"S. Trifilio","year":"2007","unstructured":"Trifilio S, Singhal S, Williams S, et al.: Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007, 40:451\u2013456.","journal-title":"Bone Marrow Transplant"},{"key":"77_CR14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/427759","volume":"40","author":"I. Oren","year":"2005","unstructured":"Oren I: Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis 2005, 40:770\u2013771.","journal-title":"Clin Infect Dis"},{"key":"77_CR15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","volume":"191","author":"D.P. Kontoyiannis","year":"2005","unstructured":"Kontoyiannis DP, Lionakis MS, Lewis RE, et al.: Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005, 191:1350\u20131360.","journal-title":"J Infect Dis"},{"key":"77_CR16","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1086\/427752","volume":"40","author":"S. Vigouroux","year":"2005","unstructured":"Vigouroux S, Morin O, Moreau P, et al.: Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005, 40:e35\u2013e37.","journal-title":"Clin Infect Dis"},{"key":"77_CR17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","volume":"50","author":"R.N. Greenberg","year":"2006","unstructured":"Greenberg RN, Mullane K, van Burik JA, et al.: Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006, 50:126\u2013133.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR18","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","volume":"42","author":"J.A. Burik van","year":"2006","unstructured":"van Burik JA, Hare RS, Solomon HF, et al.: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006, 42:e61\u2013e65.","journal-title":"Clin Infect Dis"},{"issue":"Suppl1","key":"77_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1439-0507.2006.01299.x","volume":"49","author":"V. Rickerts","year":"2006","unstructured":"Rickerts V, Atta J, Herrmann S, et al.: Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses 2006, 49(Suppl 1):27\u201330.","journal-title":"Mycoses"},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","volume":"11","author":"B.V. John","year":"2005","unstructured":"John BV, Chamilos G, Kontoyiannis DP: Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005, 11:515\u2013517.","journal-title":"Clin Microbiol Infect"},{"key":"77_CR21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CMR.7.4.479","volume":"7","author":"P.E. Nelson","year":"1994","unstructured":"Nelson PE, Dignani MC, Anaissie EJ: Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994, 7:479\u2013504.","journal-title":"Clin Microbiol Rev"},{"key":"77_CR22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1086\/324501","volume":"33","author":"E.J. Anaissie","year":"2001","unstructured":"Anaissie EJ, Kuchar RT, Rex JH, et al.: Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 2001, 33:1871\u20131878.","journal-title":"Clin Infect Dis"},{"key":"77_CR23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","volume":"20","author":"M. Nucci","year":"2007","unstructured":"Nucci M, Anaissie E: Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695\u2013704.","journal-title":"Clin Microbiol Rev"},{"key":"77_CR24","first-page":"121","volume":"20","author":"A. Espinel-Ingroff","year":"2003","unstructured":"Espinel-Ingroff A: In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003, 20:121\u2013136.","journal-title":"Rev Iberoam Micol"},{"key":"77_CR25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jac\/dkh228","volume":"53","author":"G. Garc\u00eda-Effr\u00f3n","year":"2004","unstructured":"Garc\u00eda-Effr\u00f3n G, G\u00f3mez-L\u00f3pez A, Mellado E, et al.: In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi. J Antimicrob Chemother 2004, 53:1086\u20131089.","journal-title":"J Antimicrob Chemother"},{"key":"77_CR26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ICO.0b013e31813e32a6","volume":"26","author":"S.K. Rao","year":"2007","unstructured":"Rao SK, Lam PT, Li EY, et al.: A case series of contact lensassociated Fusarium keratitis in Hong Kong. Cornea 2007, 26:1205\u20131209.","journal-title":"Cornea"},{"key":"77_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.11510","volume":"98","author":"M. Nucci","year":"2003","unstructured":"Nucci M, Anaissie EJ, Queiroz-Telles F, et al.: Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003, 98:315\u2013319.","journal-title":"Cancer"},{"issue":"Suppl6","key":"77_CR28","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1086\/429331","volume":"40","author":"J.R. Perfect","year":"2005","unstructured":"Perfect JR: Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005, 40(Suppl 6):S401\u2013S408.","journal-title":"Clin Infect Dis"},{"key":"77_CR29","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","volume":"36","author":"J.R. Perfect","year":"2003","unstructured":"Perfect JR, Marr KA, Walsh TJ, et al.: Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003, 36:1122\u20131131.","journal-title":"Clin Infect Dis"},{"key":"77_CR30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","volume":"42","author":"I.I. Raad","year":"2006","unstructured":"Raad II, Hachem RY, Herbrecht R, et al.: Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006, 42:1398\u20131403.","journal-title":"Clin Infect Dis"},{"key":"77_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","volume":"40","author":"S. Husain","year":"2005","unstructured":"Husain S, Mu\u00f1oz P, Forrest G, et al.: Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005, 40:89\u201399.","journal-title":"Clin Infect Dis"},{"key":"77_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/338636","volume":"34","author":"S.G. Revankar","year":"2002","unstructured":"Revankar SG, Patterson JE, Sutton DA, et al.: Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002, 34:467\u2013476.","journal-title":"Clin Infect Dis"},{"key":"77_CR33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005792-199707000-00004","volume":"76","author":"J. Berenguer","year":"1997","unstructured":"Berenguer J, Rodr\u00ediguez-Tudela JL, Richard C, et al.: Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 1997, 76:256\u2013265.","journal-title":"Medicine (Baltimore)"},{"key":"77_CR34","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(00)04423-8","volume":"357","author":"A. Guerrero","year":"2001","unstructured":"Guerrero A, Torres P, Dur\u00e1n MT, et al.: Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001, 357:1267\u20131268.","journal-title":"Lancet"},{"key":"77_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","volume":"37","author":"S. Husain","year":"2003","unstructured":"Husain S, Alexander BD, Mu\u00f1oz P, et al.: Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003, 37:221\u2013229.","journal-title":"Clin Infect Dis"},{"key":"77_CR36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1439-0507.1995.tb00022.x","volume":"38","author":"R. Ruchel","year":"1995","unstructured":"Ruchel R, Wilichowski E: Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995, 38:473\u2013475.","journal-title":"Mycoses"},{"key":"77_CR37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1399-3062.2002.02008.x","volume":"4","author":"A. Safdar","year":"2002","unstructured":"Safdar A, Papadopoulos EB, Young JW: Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiosis and recent advances in antifungal therapy. Transpl Infect Dis 2002, 4:212\u2013217.","journal-title":"Transpl Infect Dis"},{"key":"77_CR38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkm518","volume":"61","author":"A. Espinel-Ingroff","year":"2008","unstructured":"Espinel-Ingroff A, Johnson E, Hockey H, Troke P: Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J Antimicrob Chemother 2008, 61:616\u2013620.","journal-title":"J Antimicrob Chemother"},{"key":"77_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","volume":"21","author":"K.J. Cortez","year":"2008","unstructured":"Cortez KJ, Roilides E, Quiroz-Telles F, et al.: Infections caused by Scedosporium spp. Clin Microbiol Rev 2008, 21:157\u2013197.","journal-title":"Clin Microbiol Rev"},{"key":"77_CR40","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/AAC.45.7.2151-2153.2001","volume":"45","author":"A.J. Carrillo","year":"2001","unstructured":"Carrillo AJ, Guarro J: In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001, 45:2151\u20132153.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.46.1.62-68.2002","volume":"46","author":"J. Meletiadis","year":"2002","unstructured":"Meletiadis J, Meis JF, Mouton JW, et al.: In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002, 46:62\u201368.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","volume":"47","author":"J. Meletiadis","year":"2003","unstructured":"Meletiadis J, Mouton JW, Meis JF, Verweij PE: In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003, 47:106\u2013117.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR43","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/AAC.46.10.3323-3326.2002","volume":"46","author":"J. Afeltra","year":"2002","unstructured":"Afeltra J, Dannaoui E, Meis JF, et al.: In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother 2002, 46:3323\u20133326.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR44","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/AAC.49.12.5157-5159.2005","volume":"49","author":"K. Heyn","year":"2005","unstructured":"Heyn K, Tredup A, Salvenmoser S, Muller FM: Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother 2005, 49:5157\u20135159.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/gfg433","volume":"19","author":"D. Reimann","year":"2004","unstructured":"Reimann D, Bussemaker E, Gross P: Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient. Nephrol Dial Transplant 2004, 19:245\u2013248.","journal-title":"Nephrol Dial Transplant"},{"key":"77_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.qco.0000235164.70678.97","volume":"19","author":"P. Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz P, Singh N, Bouza E: Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? Curr Opin Infect Dis 2006, 19:365\u2013370.","journal-title":"Curr Opin Infect Dis"},{"key":"77_CR47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mpo.1180","volume":"37","author":"D. Barbaric","year":"2001","unstructured":"Barbaric D, Shaw PJ: Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole. Med Pediatr Oncol 2001, 37:122\u2013125.","journal-title":"Med Pediatr Oncol"},{"key":"77_CR48","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/340522","volume":"34","author":"I.K. Mellinghoff","year":"2002","unstructured":"Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ: Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002, 34:1648\u20131650.","journal-title":"Clin Infect Dis"},{"key":"77_CR49","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/AAC.46.7.2234-2237.2002","volume":"46","author":"C. Gil-Lamaignere","year":"2002","unstructured":"Gil-Lamaignere C, Roilides E, Mosquera J, et al.: Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother 2002, 46:2234\u20132237.","journal-title":"Antimicrob Agents Chemother"},{"key":"77_CR50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/49.3.525","volume":"49","author":"M. Ortoneda","year":"2002","unstructured":"Ortoneda M, Capilla J, Pujol I, et al.: Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother 2002, 49:525\u2013529.","journal-title":"J Antimicrob Chemother"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-008-0077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-008-0077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-008-0077-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:22:09Z","timestamp":1559434929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-008-0077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s11908-008-0077-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}